HIGHLIGHTS
- who: Can Xu from the StJohn`s University, United States have published the research: lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy, in the Journal: (JOURNAL)
- what: Frontiers in Oncology | www.frontiersin.org MATERIAL AND METHODS Cell Lines and Cell Transfection Culture methods of the primary cell lines (N33, N9, and TBD0220) used in this study have been previously reported . The experiments were performed on a Seahorse XF24 Analyzer (Seahorse Bioscience) as described elsewhere . The authors showed PRADX was highly expressed in mesenchymal GBM and transcriptionally regulated by the RUNX1-CBFb . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.